Pharmexa-Epimmune initiates Phase I AIDS trial.
D016915:AIDS Vaccines / Q000276:immunology; D004345:Drug Industry; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D010919:Placebos
D016915:AIDS Vaccines; D010919:Placebos